Search Within

Diane Lauren Reidy

  1. "Society of Nuclear Medicine"
Formats
  1. Journal Article (2)
  2. Review (2)
  3. Correspondence (1)
  4. Editorial (1)
  5. Meeting Abstract (1)
Groups
  1. Center for Pancreatic Cancer Research (7)
  2. Department of Medicine (7)
  3. Gastrointestinal Oncology Service (7)
  4. Radiology, Department of (7)
  5. Solid Tumor Oncology Division (7)
  6. Molecular Imaging and Therapy Service (6)

More Groups

People
  1. Lisa Bodei (5)
  2. Heiko Schoder (2)
  3. Kinh Gian Do (2)
  4. Nitya Raj (2)
  5. Simone Krebs (2)
  6. Audrey Mauguen (1)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2021 (2)
  4. 2020 (2)
  5. 2018 (1)
Publications
  1. Journal of Nuclear Medicine (7)
Publishers
  1. Society of Nuclear Medicine (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequencing of somatostatin-receptor–based therapies in neuroendocrine tumor patients
    Review

    Strosberg, J. R.; Al-Toubah, T.; El-Haddad, G.; Lagunes, D. R.; Bodei, L.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Radioembolization versus bland or chemoembolization for liver-dominant neuroendocrine tumors: Is it an either/or question?
    Editorial

    Strosberg, J.; El-Haddad, G.; Al-Toubah, T.; Reidy-Lagunes, D.; Ziv, E.; Mahvash, A.; Dasari, A.; Philip, P.; Soulen, M. C.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy during the COVID-19 pandemic: Are there any concerns?
    Correspondence

    Bodei, L.; Bergsland, E.; de Herder, W. W.; Ferone, D.; Hicks, R. J.; Hope, T. A.; Kunikowska, J.; Pavel, M.; Reidy-Lagunes, D.; Siveke, J.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • NANETS/SNMMI consensus statement on patient selection and appropriate use of (177)Lu-DOTATATE peptide receptor radionuclide therapy
    Review

    Hope, T. A.; Bodei, L.; Chan, J. A.; El-Haddad, G.; Fidelman, N.; Kunz, P. L.; Mailman, J.; Menda, Y.; Metz, D. C.; Mittra, E. S.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Biodistribution and dosimetry of (18)F-meta-fluorobenzylguanidine: A first-in-human PET/CT imaging study of patients with neuroendocrine malignancies
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P.; Staton, K. D.; Carrasquillo, J. A.; Reidy-Lagunes, D.; Lyashchenko, S.; Burnazi, E.; Zhang, H.; Lewis, J. S.; Blasberg, R.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save